Howard Wolinsky Editor’s note: An earlier version of this story erroneously stated that Medicare has started covering use of the AI-based cancer test. Neither the company nor CMS provided Medscape with information on how much the payment will be should the agency agree to cover the test. Medicare has set a payment rate for an...
Megan Brooks The Centers for Medicare & Medicaid Services (CMS) expands behavioral health services and prioritizes “whole-person” health and behavioral health care in its final physician payment rule for 2024. “The CMS Behavioral Health Strategy endeavors to support a person’s emotional and mental well-being through their behavioral health care. This rule finalized some of the...
by ZACHARY BRENNAN CMS on Tuesday said it will only pay for Biogen’s Aduhelm and other FDA-approved anti-amyloid monoclonal antibodies for Alzheimer’s disease under CMS-approved randomized controlled trials. In a draft national coverage decision, which insurers nationwide are likely to follow, CMS said it’ll be looking for randomized controlled trials that “demonstrate a clinically meaningful benefit in cognition...
1. Time for physicians to prepare for impending appropriate use mandate Most cardiac imaging procedures will be subject to scrutiny under PAMA Abstract: http://annals.org/aim/article/doi/10.7326/M16-2673 URL goes live when the embargo lifts Within a year, the Centers for Medicare & Medicaid Services (CMS) will implement a provision in the Protecting Access to Medicare Act (PAMA) that requires...
